Both in Pharmaceuticals
Turn Therapeutics vs ARS Pharmaceuticals
Over the past year TTRX returned +107.7% and SPRY returned −58.2%; their daily moves had a correlation of 0.09.
TTRX +107.7% SPRY −58.2%Growth of $1, one year, split-adjusted
| Metric | TTRX | SPRY |
|---|---|---|
| Price | $10.28 | $4.03 |
| Market cap | $312.2M | $400.8M |
| Today | +0.98% | −6.71% |
| 1 month | −22.5% | −2.9% |
| 6 months | +190.0% | −51.4% |
| Year to date | +160.9% | −65.4% |
| 1 year | +145.9% | −58.5% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | — | 61.8% |
| Net margin | — | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | $4.2M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 91.8% | 73.5% |
| Short % of float | 1.9% | 43.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).